Inventor · disambiguated record
David Fink
Also filed as: FINK DAVID · FINK DAVID MARC
7 granted patents·33 citations·filing 2004–2009
80Inventor score
Files withAVENTIS PHARMA INC7
Top patents by PatentIndex Score
7 records- 0192US7772252B2Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligandsAVENTIS PHARMA INC·Filed 2009·Granted Aug 10, 2010·22 cites·20 claims
- 0271US7402672B2Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilonAVENTIS PHARMA INC·Filed 2004·Granted Jul 22, 2008·6 cites·11 claims
- 0371US7393867B2Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase IAVENTIS PHARMA INC·Filed 2007·Granted Jul 1, 2008·1 cites·16 claims
- 0469US7186724B2Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligandsAVENTIS PHARMA INC·Filed 2004·Granted Mar 6, 2007·4 cites·40 claims
- 0558US7626027B2Substituted 1H-pyrrolo[2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase IεAVENTIS PHARMA INC·Filed 2008·Granted Dec 1, 2009·0 cites·24 claims
- 0657US7652046B2Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase IAVENTIS PHARMA INC·Filed 2008·Granted Jan 26, 2010·0 cites·5 claims
- 0757US7521445B2Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligandsAVENTIS PHARMA INC·Filed 2007·Granted Apr 21, 2009·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when David Fink files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →